James M. Mock - Feb 27, 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ James Dillon, As Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Feb 27, 2025
Transactions value $
-$93,352
Form type
4
Date filed
2/28/2025, 04:30 PM
Previous filing
Jan 6, 2025
Next filing
Mar 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +1.33K +11.3% 13.1K Feb 27, 2025 Direct F1
transaction MRNA Common Stock Tax liability -$21.6K -642 -4.91% $33.58 12.4K Feb 27, 2025 Direct F2
transaction MRNA Common Stock Options Exercise +3.09K +24.91% 15.5K Feb 27, 2025 Direct F3
transaction MRNA Common Stock Tax liability -$50.2K -1.5K -9.64% $33.58 14K Feb 27, 2025 Direct F4
transaction MRNA Common Stock Options Exercise +1.33K +9.46% 15.3K Feb 27, 2025 Direct F3
transaction MRNA Common Stock Tax liability -$21.6K -642 -4.18% $33.58 14.7K Feb 27, 2025 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Performance Stock Units Options Exercise $0 -1.33K -100% $0.00 0 Feb 27, 2025 Common Stock 1.33K Direct F1, F5
transaction MRNA Restricted Stock Units Options Exercise $0 -3.09K -25% $0.00 9.28K Feb 27, 2025 Common Stock 3.09K Direct F3, F6
transaction MRNA Restricted Stock Units Options Exercise $0 -1.33K -100% $0.00 0 Feb 27, 2025 Common Stock 1.33K Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert into common stock on a one-for-one basis.
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of performance stock stock units.
F3 Restricted stock units convert into common stock on a one-for-one basis.
F4 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F5 25% of the shares subject to this performance stock unit award vested on May 31, 2024 upon determination of achievement of the performance criteria, with the remainder vesting in three (3) equal installments on August 27, 2024, November 27, 2024 and February 27, 2025.
F6 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F7 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.